Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
- Submitting institution
-
The Open University
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 1456920
- Type
- D - Journal article
- DOI
-
10.1186/s13148-016-0182-9
- Title of journal
- Clinical Epigenetics
- Article number
- 16
- First page
- -
- Volume
- 8
- Issue
- 16
- ISSN
- 1868-7075
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
-
- Citation count
- 27
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- In relation to the manuscript entitled Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer, Francesco Crea participated in data analysis and interpretation, and critically revised the submitted manuscript. This author contribution statement is a supplement to that within the output, to more clearly indicate what Crea contributed.
- Non-English
- No
- English abstract
- -